ABSTRACT Palladin is an important component of motile actin-rich structures and nucleates branched actin filament arrays in vitro. Here we examine the role of palladin during Listeria monocytogenes infections in order to tease out novel functions of palladin. We show that palladin is co-opted by L. monocytogenes during its cellular entry and intracellular motility. Depletion of palladin resulted in shorter and misshapen comet tails, and when actin-or VASP-binding mutants of palladin were overexpressed in cells, comet tails disintegrated or became thinner. Comet tail thinning resulted in parallel actin bundles within the structures. To determine whether palladin could compensate for the Arp2/3 complex, we overexpressed palladin in cells treated with the Arp2/3 inhibitor CK-666. In treated cells, bacterial motility could be initiated and maintained when levels of palladin were increased. To confirm these findings, we utilized a cell line depleted of multiple Arp2/3 complex subunits. Within these cells, L. monocytogenes failed to generate comet tails. When palladin was overexpressed in this Arp2/3 functionally null cell line, the ability of L. monocytogenes to generate comet tails was restored. Using purified protein components, we demonstrate that L. monocytogenes actin clouds and comet tails can be generated (in a cell-free system) by palladin in the absence of the Arp2/3 complex. Collectively, our results demonstrate that palladin can functionally replace the Arp2/3 complex during bacterial actin-based motility.
activates the Arp2/3 complex to one of their poles through the N-WASP-mimicking bacterial protein ActA (4) . This recruitment stimulates the force-generating, branched actin polymerization that is needed to propel L. monocytogenes within and among host cells and functions at the molecular level, similarly to lamellipodia in migrating eukaryotic cells (5) .
The actin-binding protein palladin is widely expressed in developing and adult vertebrate cells and tissues (6) (7) (8) . This multifunctional protein acts as a scaffolding protein by recruiting other actin-related proteins, such as profilin (9) , VASP (10), ␣-actinin (11), ezrin (7), PDLIM1 (12) , Eps8 (13) , and LASP-1 (8) , to actin-rich structures within the cell. Palladin can directly cross-link actin filaments, an activity that has been linked to its Ig3 domain (14) , and can generate cross-linked actin filaments when pure preparations of palladin and monomeric actin are coincubated in vitro (15) . In this study, we explore the involvement of palladin during L. monocytogenes infections and simultaneously use L. monocytogenes infections as a model to study the functional roles of palladin.
important for its normal functioning (16, 17) . We examined the influence of those regions on L. monocytogenes infections by overexpressing palladin domain mutants that acted in dominant-negative fashions ( Fig. 2A) .
The actin binding ability of palladin has been tied to three key lysine residues (K15, K18, and K51) within its C-terminally located Ig3 domain ( Fig. 2A) . When a palladin variant mutated at these residues (palladinK15/18/51A) is expressed in cells, abnormal nuclear localization of palladin and extensive cytoskeletal perturbations in cultured epithelial cells are evident (16) . We cotransfected GFP-palladinK15/18/51A (actinbinding mutant) with mKate-LifeAct into HeLa cells and viewed, via time-lapse imaging, motile bacteria during L. monocytogenes infections. We used the known nuclear localization of GFP-palladinK15/18/51A as a readout of cells that had functionally perturbed palladin and found that motile comet tails disintegrated at their distal ends, leaving behind a trail of comet tail debris ( Fig. 2B ; see Movie S3 in the supplemental material). The crumbling comet tails moved at rates approximately 2-fold slower than comet tails in cells overexpressing GFP-tagged wild-type palladin (Fig. 2C) .
The actin-associated protein VASP classically localizes to the surface of L. monocytogenes through direct interactions with the bacterial protein ActA; however, it is also present throughout the comet tail (Fig. 2D) . To assess the requirement of ActA expression on palladin recruitment to the bacterial surface, we utilized bacteria with actA deletion. Not surprisingly, palladin was unable to be redistributed to the surface of these mutant bacteria (see Fig. S3 at https://figshare.com/s/60c87e090bce18cad3ba). Due to the importance of VASP during L. monocytogenes motility (18) (19) (20) (21) and its association with palladin at actin-rich structures within the cell (17), we examined the functional role of palladin-VASP interactions during L. monocytogenes infections by using a GFP-tagged palladin construct mutated in its VASP-binding polyproline motif (GFP-palladinFPAA). We found dramatic alterations to the actin cytoskeleton in GFPpalladinFPAA-expressing cells. In these cells, abnormal cytoplasmic clumps and bar-like structures were generated that were enriched with actin and VASP (see Fig. S4A and B at https://figshare.com/s/709e87fc36ce62e52548). We could not identify these unusual structures in either GFP-palladin-or GFP-palladinK15/18/51A-expressing cells (see Fig. S4A ). We used these abnormal actin-rich formations together with GFP as convenient markers for cells that were successfully transfected with GFP-palladinFPAA. When actin clouds were examined during live infections, the filamentous actin appeared notably diffuse around nonmotile bacteria ( Fig. 2B ; see Movie S4 in the supplemental material). Strikingly, when comet tails were viewed, they became progressively thinner as they moved ( Fig. 2B ; Movie S4). The thin comet tails also remained tethered to remnants of diffuse actin clouds that had stayed behind in their original location surrounding the L. monocytogenes bacteria prior to their launch into dynamic motility ( Fig. 2B ; Movie S4). We also found that endogenous VASP was redistributed away from comet tails in GFP-palladinFPAA-expressing cells; however, its recruitment to the surface of bacteria remained unaltered (Fig. 2D) . Motility rates of bacteria in GFP-palladinFPAA-expressing cells decreased by 4-fold compared to GFP-palladin-overexpressing cells (Fig. 2C) .
To gain further insight into the thinning events occurring at comet tails, we used transmission electron microscopy. Comet tails normally exploit the Arp2/3 complex to generate a branched actin filament network. We found that the arrangement of F-actin throughout the thinned GFP-palladinFPAA comet tails contained parallel arrays of F-actin, whereas mock-transfected and GFP-palladin-transfected cells did not (Fig. 2E to GЉ). Collectively, these findings show that the actin-binding and scaffolding roles of Palladin compensates for the Arp2/3 complex during L. monocytogenes actinbased motility. We have recently shown that palladin can generate actin filaments in vitro (15) . Based on these findings, we investigated whether palladin's apparent actinnucleating ability could be exploited by L. monocytogenes to maintain its motility if the Arp2/3 complex was functionally defective. To do this, we examined the motility of L. monocytogenes in cells overexpressing GFP-palladin, GFP-palladinK15/18/51A, or GFP-palladinFPAA prior to (and following) perfusion of the Arp2/3 complex inhibitor CK-666 (22) . A cessation of L. monocytogenes motility has already been demonstrated in infected cells treated with CK-666 (22) . We confirmed this by live-cell imaging of L. monocytogenes infections of cells with endogenous levels of palladin and noticed an immediate disassembly of actin clouds and comet tails resulting in immotile bacteria when CK-666 was introduced ( Fig. 3A ; see Movie S5 in the supplemental material). Remarkably, when GFP-palladin was overexpressed in cells, L. monocytogenes comet tails remained motile throughout treatment with CK-666 ( Fig. 3A ; see Movie S6 in the supplemental material). Additionally, bacteria with actin clouds that were stationary prior to the addition of CK-666 in GFP-palladin-overexpressing cells were still able to generate comet tails and became motile in a manner indistinguishable from bacteria in untreated cells, suggesting that exogenous palladin is not functioning solely as a stabilizer of preexisting comet tails during treatment with CK-666 (see Movie S7 in the supplemental material). Bacterial motility was also evident in cells overexpressing GFP-palladinK15/18/51A or GFP-palladinFPAA (actin-or VASP-binding palladin mutants) after CK-666 was introduced ( Fig. 3A; see Movies S8 and S9 in the supplemental material), albeit with the crumbling and thinning comet tail phenotypes described earlier.
To gain further insight into this novel function of palladin, we tracked the speed of motile bacteria by time-lapse microscopy ( Fig. 3B) . Before the addition of CK-666, motile L. monocytogenes bacteria in cells with endogenous amounts of palladin moved at an average speed of 8.990 m/min (Fig. 3C) . Following CK-666 treatment, bacterial speeds dropped significantly to an average of 0.279 m/min (Fig. 3C) . Although the majority of motile bacteria came to a complete stop after the introduction of CK-666, a fraction of the bacteria displayed a slow (1.281 m/min), jerky movement (Fig. 3B) . Interestingly, L. monocytogenes motility rates in CK-666-treated cells overexpressing GFP-tagged wild-type palladin were unaltered upon treatment with CK-666 and displayed speeds similar to those of bacteria in wild-type cells prior to the drug treatment ( Fig. 3B and C) .
To further characterize this novel function of palladin, we set out to examine bacterial actin-based motility in cells depleted of the Arp2/3 complex. To do this, we utilized a recently established Arpc2 conditional knockout cell line (23) . In these cells, loss of the Arpc2 gene product (p34) also caused the depletion of additional Arp2/3 complex subunits, including Arp2 and Arp3 (23) . A challenge in studying L. monocytogenes infections in Arpc2 Ϫ/Ϫ cells was that the bacteria could not invade the cells. To overcome this, we preinfected wild-type cells with L. monocytogenes and then mixed the infected wild-type cells with Arpc2 Ϫ/Ϫ cells expressing GFP-palladin or the GFP Palladin Compensates for the Arp2/3 Complex ® empty vector and allowed the infection to proceed for 16 h, ultimately resulting in the cell-to-cell spread of bacteria into Arpc2 Ϫ/Ϫ cells. As expected, bacteria within Arpc2 Ϫ/Ϫ cells expressing GFP alone were unable to generate F-actin at their surface and formed intracellular clusters (Fig. 4A) . However, when Arpc2 Ϫ/Ϫ cells overexpressed GFPpalladin, L. monocytogenes generated actin-rich comet tails enriched with palladin ( Fig. 4A) , as was the case with wild-type cells expressing GFP-palladin (Fig. 4A) .
To definitively establish that palladin can induce F-actin nucleation around bacteria as well as promote the formation and elongation of actin-rich comet tails in the absence of the Arp2/3 complex, we modified a previously developed cell-free protein reconstitution assay (24) . This assay allows for the generation of actin clouds and comet tails in a cell-free system when the bacteria are mixed together with purified components of the actin polymerization machinery that include the Arp2/3 complex, profilin, cofilin, gelsolin, and F-actin. As expected, we were able to generate actin clouds and comet tails when the protein constituents contained all of the aforementioned components (Fig. 4B ). To test if purified palladin could functionally replace the Arp2/3 complex, we substituted palladin for the Arp2/3 complex. We found that full-length palladin was capable of nucleating F-actin clouds around L. monocytogenes and could polymerize comet tails behind the bacteria (Fig. 4B) . We also identified long thin palladin-generated comet tails tethered to clumps of actin (see Fig. S5 at https:// figshare.com/s/518f2e2e0875d22da012). None of these structures were generated when the actin-binding domain of palladin (Ig3-palladin) was used in place of fulllength palladin (Fig. 4B) . When a palladin variant mutated in its VASP-binding region (palladinFPAA) was used in place of the wild-type full-length form, actin clouds and comet tails associated with the bacteria failed to form (see Fig. S6 at https://figshare .com/s/dc0aeaf2a28ebc7f1508). However, this mutant form of palladin did produce two populations of F-actin arrays, linear F-actin bundles and disorganized F-actin clumps (see Fig. S6 ), that were reminiscent of the structures generated in cells overexpressing palladinFPAA (Fig. 2B) .
L. monocytogenes ActA augments the polymerization activity of the Arp2/3 complex (4). Similarly, in vitro actin polymerization rates of reaction mixtures containing both Arp2/3 and ActA are enhanced compared to reactions using Arp2/3 alone (4). Using pyrene-actin polymerization assays, we found that ActA also enhanced palladin's ability to nucleate and polymerize actin (Fig. 4C) .
DISCUSSION
In summary, we have described several novel ways that palladin influences actinrich structures generated during L. monocytogenes infections. When palladin is depleted from cells, comet tails have a tortuous morphology and a diminished length. When specific amino acids are altered, comet tails crumble and actin organization switches from branched networks to parallel arrays. Moreover, we show that palladin can functionally replace the Arp2/3 complex in infected cells as well as in a cell-free system by promoting the actin-based motility of the bacteria. How does this protein mechanistically accomplish this?
The mutation of three lysine amino acids (from K15, K18, and K51 to A) in the Ig3 domain of palladin that causes crumbling comet tails has previously been shown to severely influence the cross-linking function of the protein, diminishing it to background levels (16) . Biochemical evidence has demonstrated that when bound to actin, palladin can also dimerize, which facilitates its cross-linking activity (25) . Thus, we postulate that crumbling comet tails may arise due to the diminished ability of palladin to bind actin. In turn, this would lower palladin's ability to dimerize and thus cross-link actin filaments within the comet tail dendritic meshwork despite the known presence of other potent actin cross-linkers, such as ␣-actinin and fascin, at the comet tails (26, 27) .
Although palladin is crucial for proper comet tail formation, whether its activity is also important during listeriopod formation will require further study. We show that palladin is shed from the actin of the listeriopods, suggesting that it likely has no role in bacterial cell-to-cell spreading events. The altered distribution of actin-associated proteins that are present in comet tails but are eliminated from listeriopods has also been reported for ␣-actinin (28) . Interestingly other proteins work in the reverse manner; being recruited to listeriopods, but not comet tails (28, 29) . The differences in actin-associated components are likely due to the morphological organization of the actin filaments within the structures as comet tails contain branched actin arrays and despite Arp2/3 being present at the bacterial actin interface within listeriopods, the majority of actin within those protrusions is organized in a parallel arrangement through formins (28) (29) (30) .
The role of VASP during L. monocytogenes infections has been studied extensively at the bacterial surface where it directly binds to ActA and regulates L. monocytogenes motility rates (18, 31) . However, VASP also localizes within the comet tail, and here we show that an absence of VASP from comet tails in palladinFPAA-expressing cells dramatically influences the organization of actin filaments, changing them from branched to parallel arrays. In addition to the altered organization of F-actin within the comet tails, this mutant form of palladin also dramatically alters the cytoskeleton of the host cell itself as it generates actin-rich cytoplasmic clumps within the cell. Similar clumps were also generated in the cell-free reconstitution assays when palladinFPAA was used in place of wild-type palladin, suggesting that either the lack of the VASP binding domain itself (together with actin) or unknown interactions of the other components in the assays with this palladin mutant are responsible for the observed clumping phenotype. Others have found that the absence of VASP from actin-rich structures increases F-actin branching (32) , which may be influencing the observed actin clumps. This would be counterintuitive to our observation of "parallel" structures within the palladinFPAA comet tails. However, in those comet tails VASP remains at the bacterial surface while absent from the length of the comet tail. At the bacterial surface, VASP could function by regulating the elongation of the actin filaments by binding to barbed filament ends associated with the bacterial surface in a process dependent on binding palladin.
Our most significant discovery was the demonstration that palladin can functionally replace the Arp2/3 complex-likely through its ability to nucleate and polymerize F-actin into actin clouds and motile comet tails. We also showed that ActA further enhanced palladin's actin-nucleating activity, but to a much lesser extent than that generated by the Arp2/3 complex. The substantial disparity between Arp2/3 and palladin plus ActA nucleation/polymerization activities suggests that another mechanism could be involved during the generation of palladin-mediated actin comet tails. In addition to its known actin-nucleating and cross-linking roles, palladin is efficient at stabilizing actin filaments (15) . Palladin also dimerizes upon actin binding (25) , and this could further enhance both filament cross-linking and stabilization while also providing additional nucleation sites for actin. Thus, as an alternative strategy, palladin may use those properties to enhance its nucleating abilities at L. monocytogenes actin-rich structures.
Because palladin and the Arp2/3 complex are abundant proteins in essentially all epithelial cells, it remains unclear to what extent the replacement of the Arp2/3 complex with palladin would actually occur during in vivo infections. Our evidence that palladin itself can nucleate and extend F-actin networks in the complete absence of the Arp2/3 complex is different from what has been shown previously with ␣-actinin and fascin as these proteins can only extend actin networks generated by the Arp2/3 complex but not nucleate them (27) . Because palladin levels are highly elevated at the motile leading edge of normal (10) and wounded cells (33) (34) (35) , as well as the fact that 
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® palladin is highly upregulated in motile cancer cells (36) (37) (38) (39) , we propose a bona fide cellular function for the actin nucleation role of palladin in enhancing actin-based motility events within the cell. Overall, these findings could have broad implications for an array of cell biology (33, 40) , tumor biology (36) (37) (38) (39) 41) , and microbial pathogenesis (42) fields.
MATERIALS AND METHODS
Cell culture. Human cervical (HeLa) and Potorous tridactylus kidney (Ptk2) epithelial cells were obtained from the American Type Culture Collection (ATCC) (no. CCL-2 and CCL-56, respectively). HeLa cells were cultured in high-glucose Dulbecco's modified Eagle's medium (DMEM; Hyclone, GE Healthcare) and were supplemented with 10% fetal bovine serum (FBS; Gibco, Thermo Fisher Scientific). Ptk2 cells were cultured in 1:1 DMEM-F-12 (Hyclone, GE Healthcare) supplemented with 10% FBS. Both cell lines were maintained in a cell culture incubator (37°C, 5% CO 2 ). To obtain Arpc2 Ϫ/Ϫ cells, the parental mouse embryonic fibroblast (MEF) cell line designated 10-4 was treated with puromycin dihydrochloride (Sigma) and 4-hydroxy-tamoxifen (4-OHT; Sigma), as described previously (23) . To seed cells for experiments, flasks or culture dishes with cells were washed 3ϫ with Dulbecco's phosphate-buffered saline without Ca 2ϩ and Mg 2ϩ (PBS[Ϫ/Ϫ]) (Gibco, Thermo Fisher Scientific), trypsinized with 0.05% trypsin-EDTA (Gibco, Thermo Fisher Scientific), and seeded onto clear polystyrene 6-well plates (Corning) containing glass coverslips. For electron microscopy experiments, flexible silicone elastomer membranes (Flexcell International) were used in place of glass coverslips.
Bacterial strains and growth conditions. The bacterial strains used were the L. monocytogenes wild type EGD BUG 600 and the ΔactA mutant (a gift by Pascale Cossart). All L. monocytogenes strains were grown at 37°C using either brain heart infusion (BHI) agar or broth (BD Biosciences).
Listeria monocytogenes infections. To infect cultured cells, broth cultures of L. monocytogenes shaken overnight were diluted 10ϫ in BHI broth and then incubated at 37°C in a shaking incubator until an A 600 of 1.00. Once cultures reached an A 600 of 1.00, bacteria were spun down for 5 min at 10,000 rpm (25°C) and washed with PBS[Ϫ/Ϫ]. Pelleted bacteria were resuspended with serum-free medium and then diluted 100ϫ. Diluted bacteria were added onto culture plates containing host cells and incubated for 30 min to study bacterial internalization or at least 6 h to study comet tails and listeriopod formation. To infect Arpc2 Ϫ/Ϫ cells, wild-type cells were infected for 2 h, collected from culture plates, and overlaid onto culture plates containing uninfected Arpc2 Ϫ/Ϫ cells, where the infection was allowed to proceed for an additional 14 to 18 h.
Antibodies and reagents. The antibodies used in this study included the following: Alexa Fluor 594-, 488-and 350-conjugated phalloidin from Invitrogen; Alexa Fluor 594-, 488-, and 350-conjugated goat anti-rabbit and goat anti-mouse antibodies (2 g/ml) from Invitrogen; mouse anti-palladin antibody (50 g/ml for immunofluorescence and 500 g/ml for Western blotting) from Novus Biologicals, Inc.; rabbit anti-palladin antibody (0.002 g/ml for immunofluorescence and 0.002 g/ml for Western blotting) from the Proteintech Group; rabbit anti-VASP antibody (1.1 g/ml for immunofluorescence and 0.1 g/ml for Western blotting) from Sigma; rabbit anti-p34 antibody (10 g/ml for immunofluorescence) from Millipore; rabbit anti-actin antibody (0.1 g/ml for Western blotting) from Abcam, Inc.; rabbit anti-calnexin antibody (1:2,000 for Western blotting) from Sigma; and horseradish peroxidase (HRP)-conjugated goat anti-rabbit and goat anti-mouse antibodies (1 g/ml) from Invitrogen. The reagents used in this study included the following: purified profilin, cofilin, gelsolin, Arp2/3 complex, rhodamine-actin, skeletal actin, and ATP from Cytoskeleton, Inc.; methylcellulose CP4000 and 1,4-diazabicyclo[2.2.2]octane (DABCO) from Sigma; dithiothreitol (DTT) from Sigma-Roche; and CK-666 (100 M) from Abcam, Inc.
Immunolocalization. For immunofluorescence studies, cells were fixed at room temperature for 15 min using prewarmed (37°C) 3% paraformaldehyde (prepared in 150 mM NaCl, 4 mM Na/KPO 4 Lysate preparation and Western blotting. Lysates were prepared by washing the samples 3ϫ with prewarmed PBS[Ϫ/Ϫ] and then treating the samples with ice-chilled radioimmunoprecipitation assay (RIPA) lysis buffer (150 mM NaCl, 50 mM Tris [pH 7.4], 5 mM EDTA, 1% Nonidet P-40, 1% deoxycholic acid, 10% SDS) with cOmplete Mini EDTA-free protease inhibitor cocktail (Roche) on ice for 5 min. Cells were disrupted using cell scrapers, and lysates were collected into microcentrifuge tubes. Lysates were spun at 4°C and 10,000 ϫ g for 10 min to pellet cellular debris; supernatants were collected into fresh microcentrifuge tubes and immediately stored at Ϫ80°C. Protein concentrations were determined using a bicinchoninic acid (BCA) assay kit (Pierce). For Western blotting, lysate samples were first prepared in 6ϫ Laemmli buffer and then boiled for 10 min. Equal amounts of protein were loaded onto 10% SDS-polyacrylamide gels and subsequently resolved by electrophoresis. Following separation, gels were Palladin Compensates for the Arp2/3 Complex ® rinsed in water for 5 min and then transferred onto nitrocellulose membranes using a Trans-Blot SD semidry transfer cell (Bio-Rad). After the transfer, the membranes were washed for 5 min in TBST (Tris-buffered saline, 0.05% Tween 20), blocked with 4% Blotto (Santa Cruz Biotechnology) prepared in TBST, and then treated with primary antibodies (diluted in TBST plus 1% BSA) overnight at 4°C. Membranes were washed 3ϫ with TBST for 10 min each prior to incubation with secondary antibodies (HRP-conjugated goat anti-rabbit or goat anti-mouse antibodies) for 1 h at room temperature. Membranes were treated with Western Lightning Plus-ECL (PerkinElmer) following the manufacturer's instructions and visualized using a Fujifilm LAS-4000 imager (Fujifilm). To confirm equal loading, membranes were stripped of bound antibodies with mild stripping buffer (1.5% glycine, 0.1% SDS, 1% Tween 20 [pH 2.2]) and reprobed using antibodies targeting actin or calnexin as outlined above.
DNA constructs. All palladin constructs used consisted of the major 90-kDa isoform, commonly referred to as isoform 4. These included GFP vectors containing wild-type palladin and the actin-binding mutant GFP-palladinK15/18/51A. GFP-palladinFPAA, the VASP-binding mutant construct, was generated from the phrGFPIIN-palladin (human isoform 4) construct. For vector controls, the phrGFPIIN vector (Stratagene) was utilized. The phenylalanine and proline residues found in the polyproline region of palladin were both mutated to alanine using site-directed mutagenesis with the following primers: 5=-GTGCCCGACGTGGCCGCACTGCCGCCGCCACCA-3= and 5=-TGGTGGCGGCGGCAGTGCGGCCACGTCGGG CAC-3=. Plasmids containing mKate-LifeAct or enhanced green fluorescent protein (eGFP)-LifeAct were a gift from Michael Davidson (Addgene plasmid no. 54697 and 54610, respectively).
Microscopy and live-cell imaging. Images were acquired using a Leica DMI4000B (Leica Microsystems, Inc.) inverted fluorescence microscope fitted with a Hamamatsu Orca R2 charge-coupled device (CCD) camera (Hamamatsu Photonics). All devices were controlled by MetaMorph Imaging System software (Universal Imaging). The images obtained were evaluated using Metamorph Imaging System software or ImageJ. For live-cell imaging, a Chamlide IC top-stage incubator system was used to maintain a constant temperature and environment of 37°C and 5% humidified CO 2 gas in air. Bacterial motility rates and comet tails were analyzed using ImageJ. For CK-666 studies, DMEM (without phenol red) plus 10% FBS containing 100 M CK-666 (prepared in dimethyl sulfoxide [DMSO] ) was perfused into magnetic coverslip-containing chambers (Chamlide) during the infections at the indicated times.
Cell culture transfections. All DNA transfections of cultured cells were performed using jetPEI or jetPRIME transfection reagents (Polyplus Transfection) and were carried out according to the manufacturer's instructions. Briefly, cells were transfected and allowed to incubate at 37°C for 4 h. Following this, medium was replaced and cells were incubated for 24 h at 37°C to allow the expression of the respective gene product. Transfected cells were either fixed for viewing by immunofluorescence microscopy or imaged live by time-lapse microscopy.
Palladin RNAi knockdown. For RNA interference (RNAi) knockdown, a smart pool (ON-Targetplus siRNA) of 4 palladin siRNAs and 4 nontargeting control siRNAs was purchased from Dharmacon (GE Healthcare). Transfections were performed using the siRNA transfection reagent INTERFERin (Polyplus transfection) following the manufacturer's instructions. Briefly, 0.1 ml of serum-free medium containing 50 nM siRNA duplexes and INTERFERin was added to cells contained in clear polystyrene 24-well culture plates. To obtain cells with undetectable levels of palladin protein, cells required a 72-h incubation period following the siRNA treatment.
Electron microscopy. Medium was replaced with fixative (1.5% paraformaldehyde, 1.5% glutaraldehyde, and 0.1 M sodium cacodylate [pH 7.3] at room temperature) and left for 2 to 3 h, and then the fixative was replaced with buffer (0.1 M sodium cacodylate [pH 7.3], room temperature). The membranes, with attached cells, were gently cut away from cell culture dishes and then further cut into 1-to 2-cm 2 pieces. The pieces were placed in glass vials and then washed twice (10 min each wash) with fresh buffer. The samples were postfixed for 1 h on ice with 1% osmium tetroxide in 0.1 M sodium cacodylate (pH 7.3). The samples were washed three times (10 min each wash) with ddH 2 O (room temperature) and then stained en bloc with 1% aqueous uranyl acetate (room temperature). The membranes were again washed three times with double-distilled water (ddH 2 O; room temperature) and then dehydrated through an ascending series of ethyl alcohols (30%, 50%, 70%, 95%, 2 ϫ 100% for 10 min each) followed by two treatments with propylene oxide (15 min each). The samples were then placed in 1:1 mixture of propylene oxide and Embed 812 resin (Electron Microscopy Sciences, Hatfield, PA) and left overnight. The following day, the membranes were passed through two changes of 100% Embed 812 resin and then placed on glass slides with the cells faceup. Embedding capsules were filled with resin and inverted onto the membranes, and then the slides with membranes and embedding capsules were placed in an oven (60°C) for the resin to polymerize for 48 h. After polymerization, the capsules (with embedded cells) were carefully separated from the membranes that remained attached to the slides. The cell layers at the surfaces of the block were sectioned en face using a Leica ultramicrotome and collected onto copper grids. The sections were stained with uranyl acetate and lead citrate and then viewed, and images were collected using an FEI Tecnai G2 Spirit electron microscope operated at 120 kV.
Protein purification. Full-length 90-kDa human palladin was subcloned into the pTBSG expression vector to allow for expression of a His 6 fusion protein. The construct was transformed into Escherichia coli BL21(DE3) cells (NEB, Ipswich, MA), and cells were grown at 37°C until the optical density at 600 nm (OD 600 ) reached 0.6 in ZYM-5052 autoinduction media. Cell cultures were pelleted down and resuspended in lysis buffer (20 mM sodium phosphate, 300 mM NaCl, 2 mM DTT, 10% glycerol [pH 7.4]), followed by sonication and clearing of cell lysate by centrifugation. Supernatant was incubated with ProteIndex Ni-Penta agarose 6 Fast Flow (Marvelgent Biosciences, Inc., Canton, MA) slurry overnight at 4°C before the protein was purified according to the manufacturer's guidelines. The elution fraction was dialyzed into S-column buffer A (25 mM KH 2 PO 4 , 50 mM NaCl, 2 mM DTT [pH 6.5]) before being loaded onto a cation-exchange column on an Äkta fast protein liquid chromatography (FPLC) device (GE Healthcare) with a HiPrep SP XL column. The protein was eluted using a gradient with a target of 100% buffer B (25 mM KH 2 PO 4 , 1 M NaCl, 2 mM DTT [pH 6.5]). Fractions containing palladin were confirmed by SDS-PAGE, and protein was dialyzed into storage buffer containing 20 mM HEPES, 150 mM NaCl (pH 7.5), and 2 mM tris(2-carboxyethyl)phosphine (TCEP). Purification of L. monocytogenes ActA-His (strain DPL1545) was performed as previously described (4) . The Arp2/3 protein complex was purchased from Cytoskeleton, Inc. Actin was purified from rabbit muscle acetone powder (PelFreez Biologicals) by the method of Spudich and Watt (43) and gel filtered on a 16/60 Sephacryl S-200 column (GE Healthcare Life Sciences). Purified monomeric actin was stored at 4°C in G-buffer (5 mM Tris [pH 8], 0.1 mM CaCl 2 , 0.2 mM DTT, 0.2 mM ATP, 0.02% sodium azide) and used within 2 to 4 weeks. Pyrene-labeled actin was prepared by the reaction of N-(1-pyrenyl) iodoacetamide (Sigma-Aldrich) with gel-filtered monomeric actin (G-actin) as described previously (44) .
Reconstitution of Listeria actin clouds and comet tails using purified proteins. On the day of the experiments, fresh stocks of the following were prepared: assay buffer ( To reconstitute actin polymerization around L. monocytogenes (BUG 600), the following reagents were added in order to an Eppendorf tube (at the following final concentrations) to create the reaction mixture: 0.5% BSA, 3.7 M cofilin, 2.5 M profilin, 50 nM gelsolin, 75 nM Arp2/3 or 4.875 M palladin (full-length, Ig3-palladin, or palladinFPAA), 3.0 l ADD/24-l reaction mixture, 1 M rhodamine-G-actin, 2 ϫ 10 8 L. monocytogenes cells/ml in assay buffer, 7.6 M Mg-F-actin, and 0.23% methylcellulose. Anywhere from 2 to 5 l of the reaction mixture was spotted onto a 35-mm Fluorodish (WPI, Inc.) or standard glass microscope slide premarked with a DakoCytomation pen and then covered with a 12-mm glass circle coverslip. Coverslips were added carefully so as to not squish down against the droplet. Samples were then placed onto the microscope to begin phase-contrast as well as fluorescence microscopy observation of actin cloud and comet tail formation.
Pyrene fluorescence assay. Pyrenyl actin and unlabeled G-actin were mixed together to make 5 M 5% pyrene-labeled G-actin stock. Labeled G-actin (100 l) was incubated with (10 l) of 10ϫ priming solution (10 mM EGTA, 1 mM MgCl 2 ) for 2 min, and then polymerization was induced by adding 0.37 M Arp2/3 and 10 M full-length palladin with or without 0.3 M ActA. All reactions were performed in G-buffer (without KCl). Pyrene fluorescence was measured immediately with excitation at 365 nm and emission at 385 nm on a PTI fluorescence spectrometer.
Statistical analysis. Statistical analysis was performed with Student's unpaired t test (Mann-Whitney U test for nonparametric tests) or 1-way analysis of variance (ANOVA) with the Tukey post hoc test when comparing means of two or more groups in GraphPad Prism version 6.01. All data are presented as bar graphs with mean Ϯ standard error of the mean (SEM) unless indicated otherwise. Experiments were performed at least 3 times (n ϭ 3), and the person who performed the experiment performed all of the enumeration and statistical analyses. All data involving immunofluorescence microscopy were obtained from experiments performed at least 3 times (n ϭ 3). The presented microscopy images are representative of experiments performed. In Fig. 1C , at least 45 comet tails were measured per condition per experiment (230 and 162 comet tails in total were measured in control and knockdown cells, respectively). In Fig. 1D , at least 45 comet tails were measured per condition per experiment (116 and 110 comet tails in total were measured in control and knockdown cells, respectively). Data in Fig. 1C depict average values (Ϯstandard deviation) from 3 independent experiments, with the 99% confidence interval indicated by an asterisk. Data in Fig. 1D depict average values (Ϯstandard error) from 3 independent experiments, with the 99% confidence interval indicated by an asterisk. In Fig. 2C , data show average values (Ϯstandard error) from at least 10 rate measurements, which were performed per group over the course of 3 independent experiments, with 99% confidence intervals indicated by asterisks. For Fig. 3B , the instantaneous speeds of 19, 16, 13, and 4 bacteria in cells expressing mKate-LifeAct, mKate-LifeAct and GFP-palladin, mKate-LifeAct and GFP-palladinK15/18/51A, or mKate-LifeAct and GFP-palladinFPAA, respectively, were measured with the total time of bacteria being measured ranging from a minimum of approximately 5 min up to approximately 10 min. For Fig. 3C , data show average values (Ϯstandard error), with 90% and 99% confidence intervals indicated by asterisks.
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